Medical director of San Antonio’s Heartland National TB Center named tuberculosis clinician of the year
Tuesday, July 13, 2010San Antonio – Barbara Seaworth, MD, medical director and principal investigator for the Heartland National TB Center, received the first “TB Clinician of the Year” award on June 23, 2010, during the National TB Conference held in Atlanta, Ga.
The award, named after famed scholar and physician, Dr. William W. Stead, is bestowed upon a tuberculosis physician for outstanding patient care services.
Sponsors of the award are the National Tuberculosis Controllers Association and the National Society of TB Clinicians.
The Heartland Center is a joint project between The University of Texas Health Science Center at Tyler and the Texas Department of State Health Services.
It provides training, technical assistance, and medical consultation for TB in a 13-state region from its headquarters in San Antonio.
Dr. Seaworth has dedicated herself to providing excellent care to patients with TB for more than 23 years. She started her career as an infectious disease specialist at Wright Patterson U.S. Air Force Medical Center in 1982.
In 1987, Dr. Seaworth joined the staff of the Texas Center for Infectious Diseases (TCID), a public health hospital in San Antonio that treats patients with TB and is overseen by UTHSCT.
In 1993, she became a TB consultant for the Texas Department of State Health Services and was appointed director of what was then the TB Resource and Education Center.
As a nationally recognized expert in the care of patients with multidrug-resistant- and extensively drug-resistant-TB, Dr. Seaworth holds an outpatient clinic for the most difficult TB cases in Texas on the TCID campus.
Dr. Seaworth is a Fellow of the Infectious Diseases Society of America and is a member of its TB committee. She serves on the Advisory Council for the Elimination of TB of the Texas Health and Human Services Commission.
In addition, she has served on the Scientific Agenda Review Panel and External Peer Review Panel of the Tuberculosis Trials Consortium. The consortium is an international organization funded by the U.S. Centers for Disease Control and Prevention that investigates new TB drugs and treatment strategies.
Dr. Seaworth and the other experts on these review panels offer their independent evaluation of the scientific value of research proposals involving TB drugs and therapies.
For 60 years, The University of Texas Health Science Center has provided excellent patient care and cutting-edge treatment, specializing in pulmonary disease, cancer, heart disease, primary care, and the disciplines that support them. UTHSCT’s annual operating budget of $125 million represents a major economic impact of over $287 million to the Northeast Texas region. In FY 2009, scientists in the Center for Biomedical Research were awarded 80 competitive grants and contracts totaling $14.6 million. As the academic medical center for Northeast Texas, its graduate medical education program – with residencies in family medicine and occupational medicine – provide doctors for many communities throughout the region and beyond.